Skip to main content
Fig. 2 | EJNMMI Research

Fig. 2

From: Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [111In-DOTA]MG11—first estimates for clinical translation

Fig. 2

Stability of [111In-DOTA]MG11 in peripheral mouse blood at 5 min pi. Analysis by HPLC (system 2) of murine blood collected 5 min after injection of [111In-DOTA] MG11 with a vehicle (<4 % intact radiotracer), b PA (300 μg; >70 % intact radiopeptide), c TO (150 μg; >70 % intact radiopeptide), or d 30–40 min after ip injection of Race (2 mg; >70 % intact radiopeptide). The t R of [111In-DOTA]MG11 is indicated by the arrow

Back to article page